Form 483

Cape Drugs Form 483, 2021-12-02

FDA issued a Form 483 to Cape Drugs on 2021-12-02 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Cape Drugs · Annapolis, United States · Issued December 2, 2021

Overview

  • 3 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Dec 2021
FDCA 501(a)(2)(A)

Air flow quality, higher classified area

Cited by Sena G Dissmeyer, Kathleen M Jordan

2 Dec 2021
FDCA 501(a)(2)(A)

Cleanliness, ISO-classified areas

Cited by Sena G Dissmeyer, Kathleen M Jordan

2 Dec 2021
FDCA 501(a)(2)(A)

Disinfectant contact time

Cited by Sena G Dissmeyer, Kathleen M Jordan

Inspected site

CDCape DrugsAnnapolis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere